Ascentage Pharma Group Internat AAPG
Set alert
13.56 USD -0.90 -6.20%
At close · Nov 2
13.56 0.00 0.00%
After hours · Nov 2, 4:00 PM ET
13.46 Day range 14.23
13.46 52-week range 34.50
- YTD
- -48.32%
- 1 year
- -59.43%
- Open
- 14.23
- Prev close
- 14.46
- Mkt cap
- 1.27B
- Vol
- 5.53K
- Avg vol
- 6.95K
- EPS
- -2.26
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 13.46
- High
- 14.23
- Forward P/E
- -20.93
- Beta
- 0.77
- Short ratio
- 2.74
- Inst. own
- 0.04%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Mar 31, 2027
- 50-d avg
- 15.87
- 200-d avg
- 20.15
- 1y target
- 44.50
5D chart
Signals (7)
| Name | Time | Ago |
|---|---|---|
| MACD: Buy Signal | Oct 30, 4:00 PM | 3 days ago |
| SMA: Bullish | Oct 30, 3:40 PM | 3 days ago |
| SMA: Bearish | Oct 30, 2:05 PM | 3 days ago |
| SMA: Bullish | Oct 30, 1:00 PM | 3 days ago |
| RSI: Oversold | Oct 30, 9:30 AM | 4 days ago |
| SMA: Bearish | Oct 29, 9:30 AM | 5 days ago |
| SMA: Bullish | Oct 28, 9:30 AM | 6 days ago |
Analyst view
Consensus: none
Price target (mean) 44.50 +228.2% upside
Now 13.56
- Target (low)
- 33.00
- Target (mean)
- 44.50
- Target (high)
- 55.00
Ratings (0m) 11 11 buy · 0 hold · 0 sell
- Strong buy3
- Buy8
- Hold0
- Sell0
- Strong sell0
Recommendation trend
- This month 11
- 1 month ago 8
- 2 months ago 8
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -0.56044 | -0.62 – -0.50087 | 0.00 | 0.0% | 178.31M | 0.0% | 2 |
| Next quarter | -0.50544 | -0.51 – -0.50087 | 0.00 | 0.0% | 199.41M | 0.0% | 2 |
| Current year | -1.18 | -2.38 – -0.57 | -2.00 | +41.1% | 677.61M | +18.0% | 6 |
| Next year | -0.64702 | -2.05 – 0.045 | -1.18 | +45.1% | 1.44B | +111.9% | 6 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 16, 2026 | William Blair | Initiated | — | Outperform |
| Oct 14, 2026 | Citigroup | Initiated | — | Buy |
| Oct 13, 2026 | Citizens | Initiated | — | Market Outperform |
| Oct 8, 2026 | JP Morgan | Maintained | Overweight | Overweight |
| Aug 21, 2026 | BTIG | Reiterated | Buy | Buy |
| Jun 15, 2026 | BTIG | Reiterated | Buy | Buy |
| Jun 10, 2026 | B. Riley Securities | Initiated | — | Buy |
| Apr 13, 2026 | BTIG | Reiterated | Buy | Buy |
| Mar 26, 2026 | BTIG | Reiterated | Buy | Buy |
| Dec 4, 2025 | Oppenheimer | Initiated | — | Outperform |
| Nov 24, 2025 | Truist Securities | Initiated | — | Buy |
| Nov 10, 2025 | BTIG | Initiated | — | Buy |
| Nov 5, 2025 | Piper Sandler | Initiated | — | Overweight |
| Mar 27, 2025 | JP Morgan | Initiated | — | Overweight |